Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase Iib Randomized, Placebo-Controlled Trial of an Nsaid for the Mod-261025140
Cleveland Clinic Lerner, Cleveland, OH, United States
Search grants from Cleveland Clinic Lerner
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Mitochondrial bioenergetics is associated with aggressive breast cancer growth
Hematopoietic/erythropoietic differentiation of human embryonic stem cells
Aerobic fitness, mitochondrial dysfunction, and fatty liver disease
Role of Oril and Oris in HSV-1 Pathogenesis
Pathogenesis of Fever in Humans
Recently added grants:
Facilitating Sustainment Through Implementation Feedback: The SIC Coaching Model
Epigenetic Regulation Of Striatal Circuit Function For Action And Habit Learning
The chondrocranium in craniofacial development and disease
Mechanisms of fat regulation by conserved anti-obesity genes
Control of PGC1alpha Translation and Function
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA025140-000
Application #
6688663
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2002
Total Cost
Indirect Cost
Institution
Name
Cleveland Clinic Lerner
Department
Type
DUNS #
017730458
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Related projects
NIH 2003
N01 CA
Phase Iib Randomized, Placebo-Controlled Trial of an Nsaid for the Mod-261025140
/ Cleveland Clinic Lerner
NIH 2002
N01 CA
Phase Iib Randomized, Placebo-Controlled Trial of an Nsaid for the Mod-261025140
/ Cleveland Clinic Lerner
Comments
Be the first to comment on this grant